Biogen looks good for ALS

By Megan Brodie 2 years ago | In Companies, Products
  • 2 years ago

23 September 2022 Biogen’s new therapy targeting superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS)…

This is subscriber-only content. Please login to continue reading.